Cargando…

P339: DEVELOPMENT OF ANTI-IL-7RΑ ANTIBODIES AS A TARGETED THERAPY FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

Detalles Bibliográficos
Autores principales:	Duque, Mafalda, Santos, João, Andrade, Sílvia, Teixeira, Daniela, Pajuelo, Maria, Fragoso, Rita, Barata, João T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428358/ http://dx.doi.org/10.1097/01.HS9.0000968268.99374.53

Ejemplares similares

P1379: DEVELOPMENT OF A GENE THERAPY CELL DEATH-INDUCING SYSTEM REGULATED BY MICRORNAS FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA.
por: Duque, Mafalda, et al.
Publicado: (2023)

Overexpression of wild-type IL-7Rα promotes T-cell acute lymphoblastic leukemia/lymphoma
por: Silva, Ana, et al.
Publicado: (2021)

A fully human anti-IL-7Rα antibody promotes antitumor activity against T-cell acute lymphoblastic leukemia
por: Akkapeddi, Padma, et al.
Publicado: (2019)

NRARP displays either pro- or anti-tumoral roles in T-cell acute lymphoblastic leukemia depending on Notch and Wnt signaling
por: Pinto, Inês, et al.
Publicado: (2019)

IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia: An update
por: Oliveira, Mariana L., et al.
Publicado: (2019)

Interleukin-7 receptor α mutational activation can initiate precursor B-cell acute lymphoblastic leukemia
por: Almeida, Afonso R. M., et al.
Publicado: (2021)

MiR-146b negatively regulates migration and delays progression of T-cell acute lymphoblastic leukemia
por: Correia, Nádia C., et al.
Publicado: (2016)

Mutant IL7R collaborates with MYC to induce T-cell acute lymphoblastic leukemia
por: Oliveira, Mariana L., et al.
Publicado: (2022)

Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias
por: Shochat, Chen, et al.
Publicado: (2011)

Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias
por: Shochat, Chen, et al.
Publicado: (2011)

PS 339-563
Publicado: (2005)

Activation of PI3K Is Indispensable for Interleukin 7–mediated Viability, Proliferation, Glucose Use, and Growth of T Cell Acute Lymphoblastic Leukemia Cells
por: Barata, Joao T., et al.
Publicado: (2004)

microRNAs regulate TAL1 expression in T-cell acute lymphoblastic leukemia
por: Correia, Nádia C., et al.
Publicado: (2016)

Health Tract No. 339: The Liver
Publicado: (1868)

Inhibiting Janus Kinase 1 and BCL-2 to treat T cell acute lymphoblastic leukemia with IL7-Rα mutations
por: Senkevitch, Emilee, et al.
Publicado: (2018)

LncRNA T-UCR Uc.339/miR-339/SLC7A11 Axis Regulates the Metastasis of Ferroptosis-Induced Lung Adenocarcinoma
por: Zhang, Ning, et al.
Publicado: (2022)

ODP339 Nonfunctioning Giant Adenomas
por: Oliveira, Miriam C, et al.
Publicado: (2022)

339. OPAT Outcomes in Patients with Immunocompromise
por: Mahoney, Monica V, et al.
Publicado: (2023)

PI3K inhibition synergizes with glucocorticoids but antagonizes with methotrexate in T-cell acute lymphoblastic leukemia
por: Silveira, André Bortolini, et al.
Publicado: (2015)

Interleukin-7 receptor-α gene mutations are not detected in adult T-cell acute lymphoblastic leukemia
por: Rozovski, Uri, et al.
Publicado: (2014)

339 Sensitization to Contactants in Patients with Atopic Dermatitis
por: Matsumoto, Fausto, et al.
Publicado: (2012)

Recent updates for antibody therapy for acute lymphoblastic leukemia
por: Li, Le, et al.
Publicado: (2020)

339. An Unusual Complication After Dental Procedure Prophylaxis
por: Nagori, Maria, et al.
Publicado: (2018)

A Novel t(5;7)(q31;q21)/CDK6::IL3 in Immature T-cell Acute Lymphoblastic Leukemia With IL3 Expression and Eosinophilia
por: Pierini, Valentina, et al.
Publicado: (2022)

IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study
por: Li, Yunlei, et al.
Publicado: (2016)

P319: IL7-RECEPTOR EXPRESSION IS FREQUENT IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND PREDICTS SENSITIVITY TO JAK-INHIBITION
por: Courtois, Lucien, et al.
Publicado: (2023)

Unilateral leukemic infiltration and acute angle closure as the first sign of B-cell acute lymphoblastic leukemia relapse
por: Silva, Diana, et al.
Publicado: (2019)

Emerging Monoclonal Antibody Therapy for the Treatment of Acute Lymphoblastic Leukemia
por: Abuasab, Tareq, et al.
Publicado: (2021)

Coexistence of EZH2, NOTCH1, IL7R, and PHF6 Mutations in Adult T-cell Acute Lymphoblastic Leukemia
por: Zhou, Xilian, et al.
Publicado: (2017)

High-Altitude Pulmonary Edema in Ohio at an Elevation of 339 Meters
por: Walker, Christina, et al.
Publicado: (2021)

SAT339 Osteopenia In The Setting of Mild Autonomous Cortisol Secretion
por: Mao, Jimmy J, et al.
Publicado: (2023)

Association of Klotho gene Expression and miRNA- 339 in Schizophrenia
por: Yadav, D., et al.
Publicado: (2023)

Immunotherapy of Acute Lymphoblastic Leukemia and Lymphoma With T Cell–Redirected Bispecific Antibodies
por: Lussana, Federico, et al.
Publicado: (2021)

MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia
por: Canté-Barrett, K, et al.
Publicado: (2016)

JAK/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias
por: Delgado-Martin, C, et al.
Publicado: (2017)

Expression of CXCL8 (IL-8) in the Pathogenesis of T-Cell Acute Lymphoblastic Leukemia Patients
por: Pandey, Sandeep, et al.
Publicado: (2023)

Acute lymphoblastic leukemia
por: Schrappe, Martin
Publicado: (2018)

Exam ref 70-339: managing Microsoft Sharepoint Server 2016
por: Lanphier, Troy
Publicado: (2016)

339. COVID-19 Mortality in a Private Hospital in Mexico City
por: Ruiz, Maria Lorena Cabrera, et al.
Publicado: (2021)

P339 A study of environmental risk factors in chronic rhinosinusitis
por: Singha, S. Krishna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l8at60qiu7buaue8d4rijij3c9